Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analyse

Revenio: Getting back on track before long

Af Juha KinnunenAnalytiker
Revenio Group
Download analyse (PDF)

The Q2 result was weaker than expected, but the outlook for 2023 remained unchanged. In our view, the current period of weakness is transitory and there have been no major changes in longer-term fundamentals. The company will return to strong earnings growth next year, although there is considerable uncertainty around the rate of the growth. Valuation (2024e EV/EBIT 18x) is below peers, but this will change as growth bounces back and confidence in the future returns.

Revenio Group

23,2EUR10.08.2023, 18.00
26EURKursmål
Akkumulér
Ændret fra:Akkumulér
Anbefaling opdateret:11.08.2023

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Read more on company page

Key Estimate Figures11.08.2023

202223e24e
Omsætning97,095,9107,6
vækst-%23,1 %-1,2 %12,3 %
EBIT (adj.)30,926,232,1
EBIT-% (adj.)31,8 %27,4 %29,9 %
EPS (adj.)0,860,740,93
Udbytte0,360,370,44
Udbytte %0,9 %1,3 %1,6 %
P/E (adj.)44,638,230,3
EV/EBITDA30,626,120,5
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team